246 related articles for article (PubMed ID: 29251023)
1. Autologous haematopoietic stem cell transplantation for Japanese patients with systemic sclerosis: Long-term follow-up on a phase II trial and treatment-related fatal cardiomyopathy.
Nakamura H; Odani T; Yasuda S; Noguchi A; Fujieda Y; Kato M; Oku K; Bohgaki T; Sugita J; Endo T; Teshima T; Atsumi T
Mod Rheumatol; 2018 Sep; 28(5):879-884. PubMed ID: 29251023
[TBL] [Abstract][Full Text] [Related]
2. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study.
van Bijnen S; de Vries-Bouwstra J; van den Ende CH; Boonstra M; Kroft L; Geurts B; Snoeren M; Schouffoer A; Spierings J; van Laar JM; Huizinga TW; Voskuyl A; Marijt E; van der Velden W; van den Hoogen FH; Vonk MC
Ann Rheum Dis; 2020 Aug; 79(8):1084-1089. PubMed ID: 32409324
[TBL] [Abstract][Full Text] [Related]
4. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience.
Henrique-Neto Á; Vasconcelos MYK; Dias JBE; de Moraes DA; Gonçalves MS; Zanin-Silva DC; Zucoloto TG; de Oliveira MFC; Dotoli GM; Weffort LF; Leopoldo VC; Oliveira MC
Adv Rheumatol; 2021 Feb; 61(1):9. PubMed ID: 33549135
[TBL] [Abstract][Full Text] [Related]
8. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study.
Farge D; Marolleau JP; Zohar S; Marjanovic Z; Cabane J; Mounier N; Hachulla E; Philippe P; Sibilia J; Rabian C; Chevret S; Gluckman E;
Br J Haematol; 2002 Dec; 119(3):726-39. PubMed ID: 12437652
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature.
Eyraud A; Scouppe L; Barnetche T; Forcade E; Lazaro E; Duffau P; Richez C; Seneschal J; Truchetet ME;
Br J Dermatol; 2018 Mar; 178(3):650-658. PubMed ID: 28906550
[TBL] [Abstract][Full Text] [Related]
10. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis.
Burt RK; Oliveira MC; Shah SJ; Moraes DA; Simoes B; Gheorghiade M; Schroeder J; Ruderman E; Farge D; Chai ZJ; Marjanovic Z; Jain S; Morgan A; Milanetti F; Han X; Jovanovic B; Helenowski IB; Voltarelli J
Lancet; 2013 Mar; 381(9872):1116-24. PubMed ID: 23363664
[TBL] [Abstract][Full Text] [Related]
11. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
van Laar JM; Farge D; Sont JK; Naraghi K; Marjanovic Z; Larghero J; Schuerwegh AJ; Marijt EW; Vonk MC; Schattenberg AV; Matucci-Cerinic M; Voskuyl AE; van de Loosdrecht AA; Daikeler T; Kötter I; Schmalzing M; Martin T; Lioure B; Weiner SM; Kreuter A; Deligny C; Durand JM; Emery P; Machold KP; Sarrot-Reynauld F; Warnatz K; Adoue DF; Constans J; Tony HP; Del Papa N; Fassas A; Himsel A; Launay D; Lo Monaco A; Philippe P; Quéré I; Rich É; Westhovens R; Griffiths B; Saccardi R; van den Hoogen FH; Fibbe WE; Socié G; Gratwohl A; Tyndall A;
JAMA; 2014 Jun; 311(24):2490-8. PubMed ID: 25058083
[TBL] [Abstract][Full Text] [Related]
12. Autologous Hematological Stem Cell Transplantation for Systemic Sclerosis in Israel.
Rimar D; Butbul Aviel Y; Gefen A; Nevo N; Shen-Orr SS; Starosvetsky E; Rosner I; Rozenbaum M; Kaly L; Boulman N; Slobodin G; Zuckerman T
Isr Med Assoc J; 2020 Feb; 22(2):104-110. PubMed ID: 32043328
[TBL] [Abstract][Full Text] [Related]
13. Stem cell transplant in systemic sclerosis: An Indian experience.
Nair V; Vasdev V; Kumar A; Shankar S; Nair V; Sharma A
Int J Rheum Dis; 2018 Apr; 21(4):859-865. PubMed ID: 29392863
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of fertility and pregnancy in autoimmune diseases after autologous haematopoietic stem cell transplantation.
Massenkeil G; Alexander T; Rosen O; Dörken B; Burmester G; Radbruch A; Hiepe F; Arnold R
Rheumatol Int; 2016 Nov; 36(11):1563-1568. PubMed ID: 27522225
[TBL] [Abstract][Full Text] [Related]
15. Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health-Related Quality of Life.
Maltez N; Puyade M; Wang M; Lansiaux P; Marjanovic Z; Charles C; Steele R; Baron M; Colmegna I; Hudson M; Farge D;
Arthritis Rheumatol; 2021 Feb; 73(2):305-314. PubMed ID: 32909693
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
Burt RK; Milanetti F
Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab.
Gernert M; Tony HP; Fröhlich M; Schwaneck EC; Schmalzing M
Front Immunol; 2021; 12():817893. PubMed ID: 35111167
[TBL] [Abstract][Full Text] [Related]
18. Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures.
Assassi S; Wang X; Chen G; Goldmuntz E; Keyes-Elstein L; Ying J; Wallace PK; Turner J; Zheng WJ; Pascual V; Varga J; Hinchcliff ME; Bellocchi C; McSweeney P; Furst DE; Nash RA; Crofford LJ; Welch B; Pinckney A; Mayes MD; Sullivan KM
Ann Rheum Dis; 2019 Oct; 78(10):1371-1378. PubMed ID: 31391177
[TBL] [Abstract][Full Text] [Related]
19. Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis.
van Laar JM; Naraghi K; Tyndall A
Rheumatology (Oxford); 2015 Dec; 54(12):2126-33. PubMed ID: 25953700
[TBL] [Abstract][Full Text] [Related]
20. Autologous hematopoietic stem cell transplantation reverses skin fibrosis but does not change skin vessel density in patients with systemic sclerosis.
Daikeler T; Kump E; Stern M; Hügle T; Hij A; Haeuserman P; Farge D
Pathol Biol (Paris); 2015 Sep; 63(4-5):164-8. PubMed ID: 26300240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
